- abnormal retina morphology / IMPC
- increased circulating triglyceride level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- abnormal bone structure / IMPC
- decreased regulatory T cell number / IMPC
- increased circulating bilirubin level / IMPC
- increased CD4-positive, alpha-beta T cell number / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
- increased total body fat amount / IMPC
- decreased bone mineral content / IMPC
- increased memory-marker gamma-delta T cell number / IMPC
- decreased Ly6C-positive mature NK cell number / IMPC
C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:14306 |
International strain name | C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/WtsiOrl |
Alternative name | EPD0165_5_B04 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Rwdd1tm1b(KOMP)Wtsi |
Gene/Transgene symbol | Rwdd1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0165_5_B04. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on KOMP final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- abnormal retina morphology / IMPC
- increased total body fat amount / IMPC
- decreased Ly6C-positive mature NK cell number / IMPC
- increased circulating triglyceride level / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
- abnormal bone structure / IMPC
- decreased bone mineral content / IMPC
- increased memory-marker gamma-delta T cell number / IMPC
- thrombocytopenia / IMPC
- increased CD4-positive, alpha-beta T cell number / IMPC
- decreased regulatory T cell number / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased circulating bilirubin level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).